Loading...
Locoregional treatment in intrahepatic cholangiocarcinoma: which treatment for which patient?
Bourien, H. Pircher, C. C. Guiu, B. Lamarca, Angela Valle, Juan W Niger, M. Edeline, J.
Bourien, H.
Pircher, C. C.
Guiu, B.
Lamarca, Angela
Valle, Juan W
Niger, M.
Edeline, J.
Citations
Altmetric:
Abstract
For unresectable intrahepatic cholangiocarcinoma (iCC), different locoregional treatments (LRT) could be proposed to patients, including radiofrequency ablation (RFA) and microwave ablation (MWA), external beam radiotherapy (EBRT) or transarterial treatments, depending on patient and tumor characteristics and local expertise. These different techniques of LRT have not been compared in a randomized clinical trial; most of the relevant studies are retrospective and not comparative. The aim of this narrative review is to help clinicians in their everyday practice discuss the pros and cons of each LRT, depending on the individual characteristics of their patients.
Description
Date
2023
Publisher
Collections
Files
Keywords
Type
Article
Citation
Bourien H, Pircher CC, Guiu B, Lamarca A, Valle JW, Niger M, et al. Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient? Cancers (Basel). 2023 Aug 23;15(17). PubMed PMID: 37686493. Pubmed Central PMCID: PMC10486617. Epub 2023/09/09. eng.